Novamind's clinic revenues jumped 43% quarter-over-quarter, to CAD$1.85 million. Projecting a 225% increase in clinic visits year-over-year.
A bill to legalize possession of psychedelics in California was approved by the California Senate on Tuesday.
A top U.S. health official on Wednesday touted the therapeutic potential of psychedelics like psilocybin and MDMA.
NASDAQ-listed Enveric Biosciences is merging with private psychedelics company, Magic Med Industries.
Public psychedelics companies have radically scaled-back capital raising due to low share prices. But institutional investors are still pumping large amounts of cash into private players.
Wesana's new Chief Scientific Officer has deep experience in the pharmaceutical industry with Pfizer and GSK.